In September 1986 Mojsov and Habener's team published a joint article which drew very heavily on Mojsovs experiments and analysis
Back Syn, NL, Cummings, DE, Wang, LZ, et al (2021) 'Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants', The Lancet , 397, 1830-41
In December 2022, as demand for all GLP-1 drugs skyrocketed with the news that they could be safe and effective for obesity and weight management, FDA included tirzepatide on its shortage list, which opened the floodgates for compounded copies
Retrieved from Ghusn, W., De la Rosa, A., Sacoto, D., et al
But heres the truth: Pills are often destroyed in the stomach or filtered by the liver
Treatment of HFpEF beyond the SGLT2-Is: Does the addition of GLP-1 RA improve cardiometabolic risk and outcomes in diabetic patients